COVID-19大流行前后非COVID-19危重患者的临床特征与院内死亡率比较:多中心、回顾性倾向评分匹配研究
该多中心回顾性队列研究纳入三家大学附属三级医院经急诊收入ICU的非COVID-19内科患者,比较2019年1月1日至5月31日(大流行前)与2021年1月1日至5月31日(大流行期间)的临床特征与预后,共1161例(大流行前619例、大流行期间542例)。大流行期间急诊及ICU入科时的SAPS 3与SOFA评分均显著更高(p<0.05),急诊、ICU及住院时间更长(p<0.05),院内死亡率更高(215例[39.7%] vs 176例[28.4%],p<0.001)。倾向评分匹配后两组院内死亡率无显著差异(p=0.138),COVID-19大流行未增加院内死亡风险(OR 1.405,95%CI 0.937-2.107,p=0.100)。多因素logistic回归显示SAPS 3、SOFA评分及不复苏医嘱增加院内死亡风险。作者认为这提示大流行期间医疗资源短缺对非COVID-19患者造成附带损害,需对医疗资源进行策略性管理。
要点
- 大流行期间急诊及ICU入科时SAPS 3与SOFA评分均显著高于大流行前(p<0.05),提示收治患者病情更重。
- 大流行期间急诊、ICU及住院时间均较长(p<0.05)。
- 未匹配患者院内死亡率大流行期间215例(39.7%)vs 大流行前176例(28.4%),p<0.001。
- 倾向评分匹配后两组院内死亡率无显著差异(p=0.138),大流行未增加院内死亡风险(OR 1.405,95%CI 0.937-2.107,p=0.100)。
- 多因素logistic回归中SAPS 3、SOFA评分及不复苏医嘱增加院内死亡风险。
适用人群与场景
- 三家大学附属三级医院经急诊收入ICU的非COVID-19内科患者。
- 大流行前时段为2019年1月1日至5月31日,大流行期间时段为2021年1月1日至5月31日。
研究设计与关键结果
- 研究类型为多中心、回顾性队列研究,纳入三家大学附属三级医院,共1161例患者(大流行前619例,大流行期间542例)。
- 大流行期间急诊及ICU入科时评估的SAPS 3与SOFA评分显著高于大流行前(p<0.05)。
- 大流行期间急诊、ICU及住院时间均长于大流行前(p<0.05)。
- 院内死亡率大流行期间215例(39.7%)vs 大流行前176例(28.4%),p<0.001。
- 倾向评分匹配后两组院内死亡率无显著差异(p=0.138)。
- COVID-19大流行未增加院内死亡风险(OR 1.405,95%CI 0.937-2.107,p=0.100)。
- 多因素logistic回归模型中SAPS 3、SOFA评分及不复苏医嘱增加院内死亡风险。
证据类型、等级与局限
- 证据类型:多中心、回顾性队列研究,采用倾向评分匹配。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,大流行期间未匹配患者病情更重且院内死亡率更高,提示医疗资源短缺对非COVID-19患者造成附带损害。
- 作者认为,需对医疗资源进行策略性管理以避免这些后果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The high transmission and fatality rates of coronavirus disease 2019 (COVID-19) strain intensive care resources and affect the treatment and prognosis of critically ill patients without COVID-19. Therefore, this study evaluated the differences in characteristics, clinical course, and prognosis of critically ill medical patients without COVID-19 before and during the COVID-19 pandemic.
METHODS: This retrospective cohort study included patients from three university-affiliated tertiary hospitals. Demographic data and data on the severity, clinical course, and prognosis of medical patients without COVID-19 admitted to the intensive care unit (ICU) via the emergency room (ER) before (from January 1 to May 31, 2019) and during (from January 1 to May 31, 2021) the COVID-19 pandemic were obtained from electronic medical records. Propensity score matching was performed to compare hospital mortality between patients before and during the pandemic.
RESULTS: This study enrolled 1161 patients (619 before and 542 during the pandemic). During the COVID-19 pandemic, the Simplified Acute Physiology Score (SAPS) 3 and Sequential Organ Failure Assessment (SOFA) scores, assessed upon ER and ICU admission, were significantly higher than those before the pandemic (p < 0.05). The lengths of stay in the ER, ICU, and hospital were also longer (p < 0.05). Finally, the hospital mortality rates were higher during the pandemic than before (215 [39.7%] vs. 176 [28.4%], p < 0.001). However, in the propensity score-matched patients, hospital mortality did not differ between the groups (p = 0.138). The COVID-19 pandemic did not increase the risk of hospital mortality (odds ratio [OR] 1.405, 95% confidence interval [CI], 0.937-2.107, p = 0.100). SAPS 3, SOFA score, and do-not-resuscitate orders increased the risk of in-hospital mortality in the multivariate logistic regression model.
CONCLUSIONS: In propensity score-matched patients with similarly severe conditions, hospital mortality before and during the COVID-19 pandemic did not differ significantly. However, hospital mortality was higher during the COVID-19 pandemic in unmatched patients in more severe conditions. These findings imply collateral damage to non-COVID-19 patients due to shortages in medical resources during the COVID-19 pandemic. Thus, strategic management of medical resources is required to avoid these consequences.
参考来源
- Kim S, Choi H, Sim JK, et al. Comparison of clinical characteristics and hospital mortality in critically ill patients without COVID-19 before and during the COVID-19 pandemic: a multicenter, retrospective, propensity score-matched study. Ann Intensive Care. 2022. PMID: 35731291. doi:10.1186/s13613-022-01028-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。